Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS
Report summarizes HIV/AIDS study findings from K.M. Watson and co-researchers
October 29th, 2008
"In the absence of a fully effective human immunodeficiency virus (HIV) vaccine, topical microbicides represent an important strategy for preventing the transmission of HIV through sexual intercourse, the predominant mode of HIV transmission worldwide. Although a comprehensive understanding of HIV transmission has not yet emerged in the microbicide field, it is likely the result of rapid infection of monocyte-derived cells in the vaginal mucosa by CCR5-tropic viruses," scientists writing in the journal Antimicrobial Agents and Chemotherapy report. "Inhibition of HIV transmission requires agents that prevent entry, fusion, reverse transcription, or other...
Source: Vaccine Weekly (2008-10-29)
|
